Followers

October 17, 2023

Glenmark gets ANDA approval from USFDA for apremilast tablets

As per IQVIATM sales data covering the 12-month period up to August 2023, the market for Otezla® tablets in these dosage forms achieved annual sales of around $3.7 billion.


No comments:

Post a Comment